Rapporto sull’analisi delle dimensioni del mercato e dell’analisi delle quote del mercato Screening del cancro al seno | Previsioni 2031

  • Report Code : TIPRE00009796
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 156
Buy Now

[Rapporto di ricerca] Si prevede che il mercato dello screening del cancro al seno raggiungerà i 6.209,25 milioni di dollari entro il 2027 rispetto ai 4.638,63 milioni di dollari del 2019; si stima che crescerà a un CAGR del 4,8% dal 2020 al 2027.

Il cancro al seno è il tipo di cancro più comune e diffuso tra le donne; si sviluppa nei tessuti del seno, solitamente nei dotti (tubi che trasportano il latte al capezzolo) e nei lobuli (ghiandole che producono il latte). Può verificarsi anche nel tessuto adiposo o nel tessuto connettivo fibroso all'interno del seno. La diagnosi precoce del cancro al seno è importante in quanto può impedire che la condizione diventi critica e garantire un trattamento curabile e di successo. I metodi di screening per la diagnosi del cancro al seno comprendono la mammografia, la risonanza magnetica (MRI), l'ecografia e altri. L’obiettivo principale dello screening è individuare la malattia nella sua fase più precoce e curabile. Le procedure di screening identificano i primi segni del cancro, anche prima che i sintomi inizino a manifestarsi.

Mercati regionali redditizi per lo screening del cancro al seno

Market Insights

Prevalenza del cancro al seno in crescita a livello globale

Il cancro al seno è tra le principali cause di morte nel mondo e sta influenzando profondamente la qualità della vita. Pertanto, costituisce un peso per la società se non viene diagnosticato e trattato in tempo. Secondo le stime dell’American Cancer Society, il cancro al seno è il tipo di cancro più comune negli Stati Uniti poiché ha causato morbilità in circa 234.087 persone e ha portato a 41.904 decessi nel 2018. Inoltre, nel paese sono attesi circa 276.480 nuovi casi 2020. Secondo il rapporto Globocan 2019, in Germania, il numero totale di casi di cancro al seno nel 2018 è stato di 71.888 e la malattia ha portato a circa 19.376 decessi in quell'anno. Inoltre, secondo il rapporto Globocan, nel 2018 si sono verificati circa 367.900 nuovi casi di cancro al seno e 97.972 decessi dovuti allo stesso in Cina. In India, le ONG, le agenzie governative e le organizzazioni di beneficenza stanno enfatizzando la consapevolezza del cancro al seno tra la popolazione per promuovere la diagnosi precoce, fornire moduli di trattamento completi ed estendere il supporto per la gestione del cancro al seno. Tali iniziative sono il risultato della crescente prevalenza di questo tipo di cancro nel paese. Secondo le stime del rapporto Globocan, nel 2018, l’India ha segnalato circa 162.468 nuovi casi di cancro al seno e 87.090 decessi dovuti allo stesso. La crescente prevalenza del cancro al seno in diverse regioni del mondo sta aumentando la domanda globale di dispositivi di screening per lo stesso.

Basato sul tipo di test Approfondimenti di mercato

Il mercato dello screening del cancro al seno, per tipo di prodotto, è segmentato in test dei marcatori del sangue, test di imaging, test genetici, test immunoistochimici. Il segmento dei test per immagini ha detenuto la quota maggiore del mercato nel 2019 e si prevede inoltre che registrerà il CAGR più elevato sul mercato durante il periodo di previsione.

Global Breast Mercato dello screening del cancro, per tipo di prodotto: 2018 e 2027


Approfondimenti basati sull'utente finale

Sulla base dell'utente finale, il seno Il mercato dello screening del cancro è stato segmentato in ospedali, centri diagnostici, istituti oncologici e laboratori di ricerca. Il segmento degli ospedali ha detenuto la quota maggiore del mercato nel 2019, mentre si stima che il segmento dei centri diagnostici registrerà il CAGR più elevato sul mercato durante il periodo di previsione.

Strategico Approfondimenti

Il lancio e l'approvazione dei prodotti è una strategia comunemente adottata dalle aziende nel mercato dello screening del cancro al seno per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda ampliando il proprio portafoglio di prodotti. Adottano inoltre la strategia di espansione per ampliare la base di clienti in tutto il mondo, che consente loro anche di mantenere il proprio marchio a livello globale. Ad esempio, nel giugno 2017, Siemens Healthineers ha ricevuto l'approvazione della Food and Drug Administration (FDA) per il prodotto syngo.via VB20 che probabilmente verrà utilizzato per l'imaging molecolare (MI) da Siemens Healthineers — una nuova versione del consolidato software di visualizzazione intelligente dell'azienda per l'imaging multimodale.

Mercato dello screening del cancro al seno - Per tipo di prodotto

  • Test dei marcatori del sangue
  • Test per immagini
  • Test genetico
  • Test immunoistochimico


Mercato dello screening del cancro al seno - Per applicazione

  • Centri diagnostici
  • Ospedali
  • Laboratori di ricerca
  • Istituti oncologici


Screening del cancro al seno: Per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'Asia Pacifico
  • Medio Oriente e Africa
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del Medio Oriente e Africa
  • Sud America
    • Brasile
    • Argentina
    • Resto del Sud America

Profili aziendali

  • General Electric Company
  • Siemens Healthineers AG
  • Exact Sciences Corporation
  • Koninklijke Philips NV
  • Hologic, Inc.
  • BD
  • Myriad Genetics, Inc.
  • Oncities Corporation
  • Danaher
  • POC Medical Sistemi
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are breast cancer screening mean?

The diagnosis of breast cancer is done through breast cancer screening methods such as mammography, magnetic resonance imaging (MRI), ultrasound, and others. Screening examinations are tests performed for early diagnosis of the disease. The foremost goal of screening is to detect disease at its earliest and most treatable stage.

What are the driving factors for the breast cancer screening market across the globe?

The growth of the market is attributed to some key driving factors such as increasing number of breast cancer cases, growing geriatric population and rising adoption of technology for screening purpose. However, high cost of screening method and bassinet on global business due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.

What is the regional analysis in terms of breast cancer screening?

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for breast cancer screening mean market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer, growing developments for screening and imaging process by the companies and others.

The List of Companies - Breast Cancer Screening Market

  1. Koninklijke Philips N.V..
  2. HOLOGIC, INC.
  3. BD
  4. MYRIAD GENETICS, INC.
  5. SIEMENS HEALTHCARE GMBH
  6. Exact Sciences Corporation
  7. ONCOCYTE CORPORATION
  8. POC MEDICAL SYSTEMS
  9. Danaher
  10. GENERAL ELECTRIC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports